The patient’s choice for clinical research
Finding enough Inflammatory Bowel Disease (IBD) patients for clinical trials has become a major challenge in the crowded U.S. and Western European markets.
India is an ideal new source of patients for your IBD studies
A vast population in need of healthcareThe majority of India’s more than 1.3 billion people are biologic naïve patients or patients with inadequate response on current treatments.
A significantly improved and predictable regulatory environment Intellectual property protections and approval timelines are in line with Eastern Europe’s.
An IBD disease burden similar to the West Eight years ago, the overall estimated IBD population was 1.4 million, which was the second highest number after the U.S. and one of the largest across the globe.
IBD
pop
ulat
ion
(1x
10%
)
USA
1.64
0.050.13
0.03
0.55
1.4
Sweden Japan China IndiaSouth Korea
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0
Source: karger.com
If you need a new source of patients for your IBD clinical trials.
Turn to IndiaPaving the way to successful clinical research in India
7885_SynexusIndiaBrochure_190x260mm_6pp_v8_online.indd 1-2 17/09/2018 10:47
SynexusThe largest global network of wholly-owned sites, providing patient recruitment, trial planning, management and patient retention
S4 India
Extensive local access to patients• India’s IBD standard of care ensures patients will align with protocol requirements • Our integrated approach accelerates local patient recruitment and improves patient retention• Local and global patient-centric operations enables scale-up as needed
Two specialty companies committed to the recruitment and retention of high-quality clinical research patients in India
Synexus and S4 can give you the competitive advantage you need
Together, we deliver the IBD patients and experienced sites you need
The local partner with in-depth country-specific knowledge of site and patient recruitment in India
+ =
Immediate access to India’s established clinical research infrastructure • Pool of 400+ experienced and highly qualified investigators• Network of 57 high quality sites, including 12 that specialize in gastroenterology • State-of-the-art facilities with on-site endoscopy • Experience in 15 CD and 32 UC studies
400+experienced
highly qualifiedinvestigators
Acceleratedlocal patientrecruitment
57High quality
sites
12Sites specializing
in gastroenterology
Onsiteendoscopy
Experiencein 15 CDstudies
Experience in32 UC studies
Local and global
patient-centric operations
Rapid start-up and streamlined
process
Improvedpatient
retention
Centralized project
management and robust feasibility
All-inclusive guidance
through study conduct
7885_SynexusIndiaBrochure_190x260mm_6pp_v8_online.indd 3-4 17/09/2018 10:47
Together, we pave the way for your IBD studies
All-inclusive guidance through study conduct• Up-to-date on submission processes and regulations • In-depth understanding of the healthcare system and patient flow• Versed on practical issues such as investigator selection, language, and cultural nuances
Rapid start-up and streamlined processes• Robust feasibility for evidence-based solutions • Proven Synexus quality management system• Standardized project management and SOPs • Cost efficiencies with one contract
High-quality data • Hand-picked affiliated sites with extensive experience • Consistency of study conduct across every site• Metrics-driven approach to study delivery• Dedicated ground staff supporting sites and quality oversight• Track record of successful sponsor and regulatory audits
All-inclusive guidance
Rapid start-up
High quality data
Take advantage of the emerging
IBD clinical research opportunities in India
An ideal source for
IBD patients
Partner with Synexus today US +1 480 820 5656 | UK +44 1257 230723 Email [email protected] | Visit synexus.com
With it’s vast population, major IBD burden, improved regulatory environment and strong research infrastructure, the Indian market is now emerging as an ideal source for IBD patients.
Together, Synexus and S4 can pave the way.
We can partner with you immediately in the planning and execution of a successful IBD clinical trial in India.
Contact us today to schedule a meeting
The patient’s choice for clinical research
7885_SynexusIndiaBrochure_190x260mm_6pp_v8_online.indd 5-6 17/09/2018 10:47